BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24235083)

  • 21. Hypervitaminosis D Secondary to a
    Collins L; Boehm E; Luxford C; Clifton-Bligh R; Grill V
    JBMR Plus; 2023 Sep; 7(9):e10788. PubMed ID: 37701149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
    Hawkes CP; Li D; Hakonarson H; Meyers KE; Thummel KE; Levine MA
    J Clin Endocrinol Metab; 2017 May; 102(5):1440-1446. PubMed ID: 28324001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CYP24A1 gene defect manifesting with gestational hypercalcemia].
    Györkös A; Tőke J; Sohár G; Kovács M; Goldfinger J; Vajda G; Kalmár T; Tóth M
    Orv Hetil; 2022 Jul; 163(31):1237-1242. PubMed ID: 35908214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT.
    Trutin I; Škorić I
    Acta Clin Croat; 2022 Feb; 60(3):544-547. PubMed ID: 35282483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild Idiopathic Infantile Hypercalcemia-Part 1: Biochemical and Genetic Findings.
    Lenherr-Taube N; Young EJ; Furman M; Elia Y; Assor E; Chitayat D; Uster T; Kirwin S; Robbins K; Vinette KMB; Daneman A; Marshall CR; Collins C; Thummel K; Sochett E; Levine MA
    J Clin Endocrinol Metab; 2021 Sep; 106(10):2915-2937. PubMed ID: 34125233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia.
    Gigante M; Santangelo L; Diella S; Caridi G; Argentiero L; D''Alessandro MM; Martino M; Stea ED; Ardissino G; Carbone V; Pepe S; Scrutinio D; Maringhini S; Ghiggeri GM; Grandaliano G; Giordano M; Gesualdo L
    Nephron; 2016; 133(3):193-204. PubMed ID: 27394135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Young Woman With Recurrent Gestational Hypercalcemia and Acute Pancreatitis Caused by CYP24A1 Deficiency.
    Woods GN; Saitman A; Gao H; Clarke NJ; Fitzgerald RL; Chi NW
    J Bone Miner Res; 2016 Oct; 31(10):1841-1844. PubMed ID: 27105398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperparathyroidism complicating CYP 24A1 mutations.
    Loyer C; Leroy C; Molin A; Odou MF; Huglo D; Lion G; Ernst O; Hoffmann M; Porchet N; Carnaille B; Pattou F; Kottler ML; Vantyghem MC
    Ann Endocrinol (Paris); 2016 Oct; 77(5):615-619. PubMed ID: 27378451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment.
    Nguyen M; Boutignon H; Mallet E; Linglart A; Guillozo H; Jehan F; Garabedian M
    J Pediatr; 2010 Aug; 157(2):296-302. PubMed ID: 20394945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.
    Tebben PJ; Milliner DS; Horst RL; Harris PC; Singh RJ; Wu Y; Foreman JW; Chelminski PR; Kumar R
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E423-7. PubMed ID: 22337913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel CYP24A1 Mutation in a Young Male Patient with Nephrolithiasis: Case Report.
    Jiráčková J; Hyšpler R; Alkanderi S; Pavlíková L; Palicka V; Sayer JA
    Kidney Blood Press Res; 2019; 44(4):870-877. PubMed ID: 31288237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1.
    Arnold N; O'Toole V; Huynh T; Smith HC; Luxford C; Clifton-Bligh R; Eastman CJ
    Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31751313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluconazole as a New Therapeutic Tool to Manage Patients With NPTIIc (SLC34A3) Mutation: A Case Report.
    Bertholet-Thomas A; Tram N; Dubourg L; Lemoine S; Molin A; Bacchetta J
    Am J Kidney Dis; 2019 Jun; 73(6):886-889. PubMed ID: 30765103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.
    Pronicka E; Ciara E; Halat P; Janiec A; Wójcik M; Rowińska E; Rokicki D; Płudowski P; Wojciechowska E; Wierzbicka A; Książyk JB; Jacoszek A; Konrad M; Schlingmann KP; Litwin M
    J Appl Genet; 2017 Aug; 58(3):349-353. PubMed ID: 28470390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy-Resistant Hypercalcemia in a Patient with Inactivating CYP24A1 Mutation and Recurrent Nephrolithiasis: Beware of Concomitant Hyperparathyroidism.
    David K; Khalil R; Hannon H; Evenepoel P; Decallonne B
    Calcif Tissue Int; 2020 Nov; 107(5):524-528. PubMed ID: 32743688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling.
    Kaufmann M; Schlingmann KP; Berezin L; Molin A; Sheftel J; Vig M; Gallagher JC; Nagata A; Masoud SS; Sakamoto R; Nagasawa K; Uesugi M; Kottler ML; Konrad M; Jones G
    J Bone Miner Res; 2021 Jul; 36(7):1340-1350. PubMed ID: 33856702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Diseases of Vitamin D Metabolizing Enzymes.
    Jones G; Kottler ML; Schlingmann KP
    Endocrinol Metab Clin North Am; 2017 Dec; 46(4):1095-1117. PubMed ID: 29080636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.
    Gurevich E; Borovitz Y; Levi S; Perlman S; Landau D
    Pediatr Nephrol; 2023 Apr; 38(4):1067-1073. PubMed ID: 36156733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
    Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
    Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.